Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Peringkat dalam Saham #26668
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Harga Saham
$5.54
Terakhir disinkronkan: 2024-09-18
Kapitalisasi Pasar
$38.76M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Alimera Sciences, Inc. (ALIM)

Kategori

Jumlah saham beredar untuk Alimera Sciences, Inc. (ALIM)
Jumlah saham beredar per June 2024: 54.38M
Menurut laporan keuangan terbaru dan harga saham Alimera Sciences, Inc., jumlah saham beredar saat ini adalah 54.38M. Pada akhir December 2022, perusahaan memiliki 7.00M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Alimera Sciences, Inc. (ALIM) dari 2006 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 54.38M 112.75%
2023 25.56M 265.33%
2022 7.00M 6.10%
2021 6.60M 28.86%
2020 5.12M 7.30%
2019 4.77M -18.70%
2018 5.87M 31.37%
2017 4.47M 26.88%
2016 3.52M 18.80%
2015 2.96M 10.03%
2014 2.69M 27.93%
2013 2.11M 0.38%
2012 2.10M 0.29%
2011 2.09M 0.29%
2010 2.09M 1,961.13%
2009 101.16K -6.28%
2008 107.93K 0.00%
2007 107.93K 0.00%
2006 107.93K 0.00%
Saham beredar untuk perusahaan serupa atau pesaing